AKT1 and renal cell adenocarcinoma: In RCC it has been demonstrated that recruitment of mast cells increases angiogenic behavior by modulating PI3K-AKT-GSK3β-AM signaling and that specific inhibitors are able to decrease their recruitment, thereby providing evidence that targeting this pathway is a promising new treatment strategy (36).